etazolate has been researched along with cuprizone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allinquant, B; Camand, E; Carrete, A; Chierto, E; Hendriks, JJA; Jafarian-Tehrani, M; Llufriu-Dabén, G; Mailleux, J; Massaad, C; Meffre, D; Rose, C; Simon, A; Vanmierlo, T | 1 |
| Carrete, A; Jafarian-Tehrani, M; Meffre, D; Padilla-Ferrer, A; Simon, A | 1 |
2 other study(ies) available for etazolate and cuprizone
| Article | Year |
|---|---|
Targeting demyelination via α-secretases promoting sAPPα release to enhance remyelination in central nervous system.
Topics: Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Axons; Brain; Cells, Cultured; Cerebellum; Corpus Callosum; Cuprizone; Demyelinating Diseases; Etazolate; Lysophosphatidylcholines; Male; Mice, Inbred C57BL; Myelin Sheath; Neuroprotective Agents; Remyelination | 2018 |
Effect of Etazolate upon Cuprizone-induced Demyelination In Vivo: Behavioral and Myelin Gene Analysis.
Topics: Animals; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Etazolate; Mice; Mice, Inbred C57BL; Myelin Sheath; Oligodendroglia; Phosphodiesterase Inhibitors; Remyelination | 2021 |